tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Dyskinesia, Drug-Induced D004409 15 associated lipids
Dysgammaglobulinemia D004406 3 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Down Syndrome D004314 18 associated lipids
Digestive System Diseases D004066 3 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Dermatomyositis D003882 2 associated lipids
Dermatomycoses D003881 17 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatitis D003872 30 associated lipids
Dental Pulp Calcification D003784 2 associated lipids
Dental Enamel Hypoplasia D003744 2 associated lipids
Demyelinating Diseases D003711 15 associated lipids
Dehydration D003681 11 associated lipids
Deglutition Disorders D003680 2 associated lipids
Hearing Loss, Sudden D003639 1 associated lipids
Phyllodes Tumor D003557 1 associated lipids
Cystitis D003556 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cutis Laxa D003483 1 associated lipids
Cryptococcosis D003453 3 associated lipids
Crohn Disease D003424 12 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Cough D003371 19 associated lipids
Corneal Diseases D003316 13 associated lipids
Connective Tissue Diseases D003240 2 associated lipids
Confusion D003221 4 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Collagen Diseases D003095 2 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colitis D003092 69 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Cicatrix D002921 9 associated lipids
Chronic Disease D002908 7 associated lipids
Hemophilia B D002836 3 associated lipids
Choline Deficiency D002796 16 associated lipids
Cholestasis D002779 23 associated lipids
Cholelithiasis D002769 16 associated lipids
Cheilitis D002613 2 associated lipids
Uterine Cervical Dysplasia D002578 2 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Brain Ischemia D002545 89 associated lipids
Myoclonic Cerebellar Dyssynergia D002527 1 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cataract D002386 34 associated lipids
Catalepsy D002375 30 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cardiomyopathy, Restrictive D002313 1 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Burns D002056 34 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchiolitis D001988 6 associated lipids
Brain Edema D001929 20 associated lipids
Brain Diseases D001927 27 associated lipids
Bradycardia D001919 13 associated lipids
Bone Diseases D001847 4 associated lipids
Body Weight D001835 333 associated lipids
Blindness D001766 6 associated lipids
Blepharitis D001762 4 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Biliary Fistula D001658 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Beckwith-Wiedemann Syndrome D001506 1 associated lipids
Balanitis D001446 4 associated lipids
Bacterial Infections D001424 21 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Ataxia D001259 20 associated lipids
Ascites D001201 25 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis D001168 41 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Arm Injuries D001134 1 associated lipids
Apraxias D001072 1 associated lipids
Anus Diseases D001004 3 associated lipids
Angioedema D000799 6 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Aneurysm, Dissecting D000784 2 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Anemia, Refractory D000753 3 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hemolytic D000743 4 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Stienstra NA et al. Development of a Simple and Rapid Method to Measure the Free Fraction of Tacrolimus in Plasma Using Ultrafiltration and LC-MS/MS. 2016 Ther Drug Monit pmid:27805928
Quist SR et al. Effects of Topical Tacrolimus and Polyunsaturated Fatty Acids on In Vivo Release of Eicosanoids in Atopic Dermatitis During Dermal Microdialysis. 2016 Acta Derm. Venereol. pmid:26911315
Prytula A et al. Tacrolimus Predose Concentration Is Associated With Hypertension in Pediatric Liver Transplant Recipients. 2016 J. Pediatr. Gastroenterol. Nutr. pmid:26910645
Wang X et al. Trans-11 vaccenic acid improves insulin secretion in models of type 2 diabetes in vivo and in vitro. 2016 Mol Nutr Food Res pmid:27061233
Tang J et al. ER Stress via CHOP Pathway is Involved in FK506-Induced Apoptosis in Rat Fibroblasts. 2016 Cell. Physiol. Biochem. pmid:27771715
Ghareeb M and Akhlaghi F Development and validation of a sensitive and selective LC-MS/MS method for determination of tacrolimus in oral fluids. 2016 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:27771258
Jannot AS et al. A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant Recipients. 2016 Ther Drug Monit pmid:26829596
Sayar E et al. The Ineffectiveness of Tacrolimus in an Infant With a Mutation in the IL-10 Receptor. 2016 J. Clin. Gastroenterol. pmid:26828243
Coghill AE et al. Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. 2016 Am. J. Transplant. pmid:26824445
Gathogo E et al. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. 2016 Transplantation pmid:26413990
Sienkiewicz B et al. The impact of CYP3A5 on the metabolism of cyclosporine A and tacrolimus in the evaluation of efficiency and safety of immunosuppressive treatment in patients after kidney transplantation. 2016 Pharmazie pmid:29441922
Cortes X et al. Successful use of infliximab and tacrolimus combination therapy in a patient with ulcerative colitis refractory to infliximab dose intensification plus azathioprine. 2016 Int J Clin Pharmacol Ther pmid:26754306
Bae JM et al. Repigmentation of poliosis in a patient with segmental vitiligo. 2016 J. Am. Acad. Dermatol. pmid:27317537
Wang J et al. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome. 2016 Nephrology (Carlton) pmid:26697959
Yang Y et al. STAT3 degradation mediated by calcineurin involved in the neurotoxicity of isoflurane. 2016 Neuroreport pmid:26694943
Ganetsky A et al. Higher tacrolimus concentrations early after transplant reduce the risk of acute GvHD in reduced-intensity allogeneic stem cell transplantation. 2016 Bone Marrow Transplant. pmid:26691423
Okuda K et al. Targeted Therapy for Acute Autoimmune Myocarditis with Nano-Sized Liposomal FK506 in Rats. 2016 PLoS ONE pmid:27501378
Liu S et al. The POR rs1057868-rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients. 2016 Acta Pharmacol. Sin. pmid:27498776
Wasiak D et al. Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report. 2016 Transplant. Proc. pmid:27496507
Mehraj V et al. The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response. 2016 EBioMedicine pmid:27397514
Mittal A et al. Pilot Study to Evaluate the Efficacy and Safety of Oral Tacrolimus in Adult Patients With Refractory Severe Plaque Psoriasis. 2016 J Cutan Med Surg pmid:26553734
Roblin E et al. Lipid profile and cardiovascular risk factors in pediatric liver transplant recipients. 2016 Pediatr Transplant pmid:26750745
Dunyak BM and Gestwicki JE Peptidyl-Proline Isomerases (PPIases): Targets for Natural Products and Natural Product-Inspired Compounds. 2016 J. Med. Chem. pmid:27409354
Oetting WS et al. Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles. 2016 Am. J. Transplant. pmid:26485092
Sun W et al. Activation of TRPV2 negatively regulates the differentiation of mouse brown adipocytes. 2016 Pflugers Arch. pmid:27318696
Yamanaka K et al. Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1 Year After Kidney Transplantation. 2016 Transplant. Proc. pmid:27234735
Baek CH et al. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea. 2016 Exp Clin Transplant pmid:27228054
Hošková L et al. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation. 2016 Ann. Transplant. pmid:27226081
Sommerer C and Giese T Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin Inhibitors. 2016 Ther Drug Monit pmid:26418701
Laharie D and Poullenot F Letter: which patient profile for tacrolimus in ulcerative colitis? 2016 Aliment. Pharmacol. Ther. pmid:27137730
Wei Q et al. Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma. 2016 Gut Liver pmid:27074818
Wowro SJ et al. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells. 2016 Int. Immunopharmacol. pmid:26613512
Adler M et al. A Quantitative Approach to Screen for Nephrotoxic Compounds In Vitro. 2016 J. Am. Soc. Nephrol. pmid:26260164
Ueda Y and Uemoto S Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation. 2016 Transpl. Int. pmid:26270021
Jung H and Oh ES FK506 positively regulates the migratory potential of melanocyte-derived cells by enhancing syndecan-2 expression. 2016 Pigment Cell Melanoma Res pmid:27060922
Brito-Costa A et al. Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents. 2016 Transplantation pmid:27136260
Hitzeman N and Kinnevey C Topical Tacrolimus for Eczema. 2016 Am Fam Physician pmid:27929217
Myers AL et al. Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags. 2016 Am J Health Syst Pharm pmid:27919876
Thervet É [Applied pharmacogenetic]. 2016 Nephrol. Ther. pmid:26972091
Dury S et al. Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study. 2015 BMC Pulm Med pmid:26545860
Kwon M et al. Bioequivalence of tacrolimus formulations with different dynamic solubility and in-vitro dissolution profiles. 2015 Arch. Pharm. Res. pmid:24627339
Aktürk S et al. Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. 2015 Transplant. Proc. pmid:26093738
Rahman S et al. Nordihydroguiaretic acid attenuates skin tumorigenesis in Swiss albino mice with the condition of topical co-administration of an immunosuppressant. 2015 Chem. Biol. Interact. pmid:25770929
Rossetto AM et al. The full electron structure of the FKBP12/FK506 complex. 2015 J. Biomol. Struct. Dyn. pmid:24471694
Li DW et al. Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. 2015 World J. Gastroenterol. pmid:26034369
Miura M et al. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts. 2015 Nephrology (Carlton) pmid:26031588
Ma R et al. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression. 2015 Int J Clin Exp Pathol pmid:26823720
Kaieda S et al. Successful treatment of macrophage activation syndrome in a patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis. 2015 Mod Rheumatol pmid:24252010
Kawaoka T et al. Two patients treated with simeprevir plus pegylated-interferon and ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation: case report. 2015 Transplant. Proc. pmid:25891736
Ichimaru N et al. Risk factors and incidence for lipid abnormalities in kidney transplant patients. 2015 Transplant. Proc. pmid:25891708
Bruckmueller H et al. Which Genetic Determinants Should be Considered for Tacrolimus Dose Optimization in Kidney Transplantation? A Combined Analysis of Genes Affecting the CYP3A Locus. 2015 Ther Drug Monit pmid:25271728
Moscovici BK et al. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study. 2015 Cont Lens Anterior Eye pmid:25956572
Kim D et al. Hydrogen sulfide and hypoxia-induced changes in TASK (K2P3/9) activity and intracellular Ca(2+) concentration in rat carotid body glomus cells. 2015 Respir Physiol Neurobiol pmid:25956223
Torres-Espín A et al. Immunosuppression of allogenic mesenchymal stem cells transplantation after spinal cord injury improves graft survival and beneficial outcomes. 2015 J. Neurotrauma pmid:25203134
Rojas L et al. Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies. 2015 Pharmacogenomics J. pmid:25201288
Chung YW et al. Transcriptional activation of nuclear-related factor 2 by FK506 in Jurkat T cells. 2015 Transplant. Proc. pmid:25891728
Hur J et al. Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. 2015 Chem. Res. Toxicol. pmid:25811541
Malvezzi P and Rostaing L The safety of calcineurin inhibitors for kidney-transplant patients. 2015 Expert Opin Drug Saf pmid:26329325
Hempen CM et al. Hematocrit-independent recovery of immunosuppressants from DBS using heated flow-through desorption. 2015 Bioanalysis pmid:26327182
Pidala J et al. Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease. 2015 Haematologica pmid:25840599
Tsai MK et al. B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis. 2015 J. Formos. Med. Assoc. pmid:25839769
Rajaganapathy BR et al. Intravesical Liposomal Tacrolimus Protects against Radiation Cystitis Induced by 3-Beam Targeted Bladder Radiation. 2015 J. Urol. pmid:25839382
Furlan SN et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. 2015 Sci Transl Med pmid:26606970
Nagashima T and Minota S Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. 2015 Rheumatology (Oxford) pmid:25832615
Diaz-Siso JR et al. Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. 2015 Am. J. Transplant. pmid:25777324
Fujibayashi T et al. Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry. 2015 Mod Rheumatol pmid:25775147
Lehman N et al. Left subconjunctival hemorrhage · renal dysfunction · international normalized ratio of 4.5 · Dx? 2015 J Fam Pract pmid:26551480
Boloori A et al. Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients. 2015 PLoS ONE pmid:26551468
Lightman S et al. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. 2015 Ann. Rheum. Dis. pmid:25269831
Mahajan R et al. Co-localization of agminated congenital melanocytic nevi with vitiligo vulgaris: an unusual presentation. 2015 Int. J. Dermatol. pmid:25039486
TruneÄŒka P et al. Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. 2015 Am. J. Transplant. pmid:25707487
Adam R et al. Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. 2015 Am. J. Transplant. pmid:25703527
Yokoyama Y et al. Corticosteroid-sparing effect of tacrolimus in the initial treatment of dermatomyositis and polymyositis. 2015 Mod Rheumatol pmid:25775144
Asrani SK and O'Leary JG Can one pill a day keep rejection away? 2015 Am. J. Transplant. pmid:25703394
Chen QQ et al. Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment. 2015 Chin. Med. J. pmid:26481759
Peksa GD et al. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation. 2015 J Oncol Pharm Pract pmid:24938293
Shengyou Y et al. Influence of tacrolimus on podocyte injury inducted by angiotensin II. 2015 J Renin Angiotensin Aldosterone Syst pmid:25650384
Carenco C et al. Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship. 2015 Am. J. Transplant. pmid:25648361
Mizokami D et al. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model. 2015 Laryngoscope pmid:25647147
Ferjani H et al. Tacrolimus and mycophenolate mofetil associations: Induction of oxidative stress or antioxidant effect? 2015 Hum Exp Toxicol pmid:25645822
Coelho R et al. Nodular Regenerative Hyperplasia after Liver Transplantation Complicated with Inferior Vena Cava Stenosis: a Clue for Etiopathogenesis? 2015 J Gastrointestin Liver Dis pmid:26405712
Romanowski M et al. Interleukin-17 gene polymorphisms in patients with post-transplant diabetes mellitus. 2015 Eur Rev Med Pharmacol Sci pmid:26400516
Rodríguez-Perálvarez M et al. Everolimus is safe within the first month after liver transplantation. 2015 Transpl. Immunol. pmid:26392195
Sato M et al. Multifocal Fibrosclerosis with Hypertrophic Pachymeningitis and a Soft Tissue Mass around the Thoracic Vertebral Bodies: A Case Report with Review of the Literature. 2015 Intern. Med. pmid:26328659
Chittock J et al. Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. 2015 Acta Derm. Venereol. pmid:25594610
Ge Y et al. The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review. 2015 Clin. Rheumatol. pmid:26328518
Velioglu A et al. Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients. 2015 Transplant. Proc. pmid:26093733
Demir T et al. Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy. 2015 Transplant. Proc. pmid:26093731
Yang F et al. A clinicopathological study of renal biopsies from 288 elderly patients: analysis based on 4,185 cases. 2015 Int Urol Nephrol pmid:25539617
Webb NJ et al. Corticosteroid-free Kidney Transplantation Improves Growth: 2-Year Follow-up of the TWIST Randomized Controlled Trial. 2015 Transplantation pmid:25539467
Schaap MM et al. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens. 2015 Arch. Toxicol. pmid:25270620
Yoo MC et al. Steroid-free Liver Transplantation Using Rabbit Antithymocyte Globulin Induction in 500 Consecutive Patients. 2015 Transplantation pmid:25539464
Offer K et al. Efficacy of tacrolimus/mycophenolate mofetil as acute graft-versus-host disease prophylaxis and the impact of subtherapeutic tacrolimus levels in children after matched sibling donor allogeneic hematopoietic cell transplantation. 2015 Biol. Blood Marrow Transplant. pmid:25536217
Seeling W et al. Knowledge-based immunosuppressive therapy for kidney transplant patients--from theoretical model to clinical integration. 2015 Stud Health Technol Inform pmid:26262418
Wardhana EA and Datau A patient with plaque type morphea mimicking systemic lupus erythematosus. 2015 Acta Med Indones pmid:26260557
Clift DE et al. Effects of embryonic cyclosporine exposures on brain development and behavior. 2015 Behav. Brain Res. pmid:25591474
Togashi M et al. Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease. 2015 Eur. J. Clin. Pharmacol. pmid:26184414
Spiekerkoetter E et al. Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. 2015 Am. J. Respir. Crit. Care Med. pmid:26177174
Inamoto Y et al. Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. 2015 Biol. Blood Marrow Transplant. pmid:26033280
Regelmann MO et al. New-onset diabetes mellitus after pediatric liver transplantation. 2015 Pediatr Transplant pmid:26032592